processing technique for lipofilling influences adipose-derived stem cell concentration and cell...
TRANSCRIPT
ORIGINAL ARTICLE EXPERIMENTAL/SPECIAL TOPICS
Processing Technique for Lipofilling Influences Adipose-DerivedStem Cell Concentration and Cell Viability in Lipoaspirate
Miles Pfaff • Wei Wu • Elizabeth Zellner •
Derek M. Steinbacher
Received: 14 September 2013 / Accepted: 9 December 2013 / Published online: 8 January 2014
� Springer Science+Business Media New York and International Society of Aesthetic Plastic Surgery 2014
Abstract
Background Autologous fat grafting is a highly used
technique in plastic and reconstructive surgery. Several fat-
processing techniques have been described, with centrifu-
gation frequently touted as the optimal method. Processing
is one factor important for maximizing cell viability and
adipose-derived mesenchymal stem cell (ADSC) concen-
trations. This study compared two methods of fat prepa-
ration (centrifugation vs Telfa-rolling) to determine which
technique results in the greatest degree of cell viability and
ADSC concentration.
Methods Abdominal fat was harvested from five patients.
Equal aliquots were divided and processed by both cen-
trifugation and Telfa-rolling. Samples were analyzed for
ADSC proportions via flow cytometry and cell viability
using methylene blue-based cell counting. Paired t tests
were performed on all samples, and a P value lower than
0.05 was considered statistically significant.
Results Telfa-rolling processing resulted in a higher per-
centage of isolated ADSCs (P \ 0.5 for 3 of 4 parameters)
and a significantly higher number of viable cells (P \ 0.05).
Conclusion Telfa-rolling results in a higher proportion of
ADSCs and greater cell viability than centrifugation for
donor adipose graft preparation. Further studies are nec-
essary to confirm whether optimal preparation translates to
improved augmentation and cell take at the recipient site.
Level of Evidence IV This journal requires that authors
assign a level of evidence to each article. For a full
description of these Evidence-Based Medicine ratings,
please refer to the Table of Contents or the online
Instructions to Authors www.springer.com/00266.
Keywords Telfa-rolling � Centrifugation � Fat grafting �Fat processing � Lipoaspirate � Lipoaspiration � Adipose-
derived mesenchymal stem cells Adipose-derived stem
cells � ADSC � Lipofilling
Autologous fat grafting is exceedingly popular, with broad
applicability in plastic and reconstructive surgery. Fat
grafting can impart contours and augmentation, nourish
tissue, modulate scar tissue, and exhibit regeneration at the
recipient site [1–5]. Factors taken into consideration when
fat grafting is performed include donor-site location, method
of harvest (manual vs machine-assisted liposuction), prep-
aration and injection technique, and recipient-site suitabil-
ity. Multiple techniques at all stages of the process have been
described and tested to establish a standardized, optimal
approach.
Adipose-derived mesenchymal stem cells (ADSC) are
an accessible stem cell source within lipoaspirate [6], and
accumulating evidence suggests that fat graft survival is
directly related to cell viability and may be enhanced by
increased ADSC concentrations [7].
A number of techniques have been developed and tested
to achieve the highest concentration and quality of adipo-
cytes from lipoaspirate. Centrifugation, a common method
of fat graft processing, facilitates clearance of potentially
deleterious materials (red blood cells and oil) from the
tissue sample and permits large-volume graft processing. It
is posited, however, that the process of centrifugation may
negatively influence graft survival [8, 9].
M. Pfaff � W. Wu � E. Zellner � D. M. Steinbacher (&)
Section of Plastic and Reconstructive Surgery, Yale University
School of Medicine, 3rd Floor, Boardman Building,
330 Cedar Street, New Haven, CT 06520, USA
e-mail: [email protected]; [email protected]
123
Aesth Plast Surg (2014) 38:224–229
DOI 10.1007/s00266-013-0261-7
Telfa-rolling [10], a filter-based technique that entails
spreading or rolling lipoaspirate on absorbent, nonadherent
gauze, permits simple, efficient, and atraumatic processing
without the use of equipment and may be ideal for smaller-
scale procedures.
To date, it is unclear which processing method enables
enrichment of ADSCs and fat cells from harvested tissue.
This study aimed to compare the levels of both cell via-
bility and ADSC population proportions using two differ-
ent methods of fat graft processing: centrifugation and
Telfa-rolling processing.
Materials and Methods
Patients, Fat Graft Harvesting, and Lipoaspirate
Processing
Consent was obtained from all donors before fat harvest-
ing, as indicated by the human investigation committee
(Protocol #1204010149). For fat harvesting, 10 mL of 1 %
lidocaine (with 1:100,000 epinephrine) was administered to
the donor site (on each side of the abdomen), and the lip-
oaspirate was harvested from each patient using a 10-mL
syringe under manual suction, as described previously [11].
Lipoaspiration was performed on both sides of the
abdomen to ensure optimal quality of harvested fat. For
centrifuge processing, 1 mL of lipoaspirate was placed into
a 10-mL syringe with sterile phosphate-buffered saline
(PBS) to achieve 10 mL of total volume and centrifuged at
1,500 revolutions per minute (rpm) for 3 min. The enriched
fat (supernatant) then was collected for further processing
(Fig. 1a).
For Telfa-rolling processing, the lipoaspirate was placed
on Telfa gauze pads (product used in this study, Kendall
Co., Mansfield, MA, USA) and gently rolled or spread back
and forth until it was determined that oil and blood had
been sufficiently removed (Fig. 1b) for approximately 30 s.
Then, 1 mL of processed lipoaspirate was placed in a
10-mL syringe with PBS to achieve 10 mL of total volume
for further analysis.
Cell Isolation and ADSC Population and Cell Viability
Quantification
Cells were isolated and cultured as described previously
[11]. All comparisons were made from cells cultured
before the first passage. For 60 min, 1 mL of processed fat
was digested with Dulbecco modified Eagle medium
(DMEM)-low glucose (Gibco, Grand Island, NY, USA)
containing 0.15 % collagenase I (Worthington Biochemi-
cal, Lakewood, NJ, USA) at 37 �C. Stromal vascular
fraction, the stem-cell-enriched fraction of lipoaspirate,
was collected by centrifugation, filtered through a 40-lm
strainer, and suspended in complete medium consisting of
DMEM-low glucose, 10 % fetal bovine serum (FBS)
Fig. 1 Centrifugation and Telfa-rolling techniques. a Syringes
(10 mL) are placed in a centrifuge (arrows) and spun to facilitate
clearance of potential contaminants such as blood, crystalloid, and oil
(bottom panel). b For Telfa-rolling, the lipoaspirate is placed on
nonadhesive Telfa gauze (top panel) and rolled or spread back and
forth to remove potential contaminants
Aesth Plast Surg (2014) 38:224–229 225
123
(Lonza, Allendale, NJ, USA), and 1 % penicillin–strepto-
mycin (Gibco).
The ADSC population proportions were quantified using
flow cytometry [11]. Briefly, 1 9 106 nucleated cells were
resuspended with cold fluorescence-activated cell-sorting
(FACS) buffer (PBS containing 2 % FBS) in FACS tubes.
The cells were rinsed with chilled FACS buffer and incu-
bated with all-specific conjugated primary antibody and the
corresponding isotype control.
The treated cells were rinsed with chilled FACS buffer
and analyzed in triplets using an FACS LSR-II device (BD
Biosciences, San Jose, CA, USA). The following human
antibodies were used: CD44 (fluorescein isothiocyanate),
CD73 (phycoerythrin), CD90 (alkaline phosphatase), and
CD105 (alkaline phosphatase) (BD Biosciences).
Antibody specificity is as follows: CD44 is specific to
phagocytic glycoprotein-1 and expressed on cells during
hematopoiesis and lymphocyte activation; CD73 is specific
to ecto-50 nucleotidase and expressed on mesenchymal
stem cells; CD90, a protein expressed by a small subset of
human fetal liver cells, cord blood cells, and bone marrow
cells, is believed to be useful for identifying high prolif-
erative potential colony-forming cells; and CD105 is an
integral membrane homodimer protein expressed on mes-
enchymal stem cells.
Isolated cells from individual donors were mixed with
3 % acetic acid using methylene blue (STEMCELL Tech-
nology; Vancouver, Canada), and the number of nonstained
nucleated cells was quantified under phase-contrast
microscopy (Carl Zeiss, Oberkochen, Germany).
Statistical Analysis
Statistical analysis was performed using Microsoft Excel,
version 14.0.0 (Microsoft Office 2011; Microsoft; Red-
mond, WA, USA) and SPSS Statistics, version 19 (IBM,
Armonk, NY, USA). The mean value was calculated and
reported with the standard deviation. A paired t test was
performed to compare cell viability counts and ADSC
population proportions. An observed P value of 0.05 was
considered statistically significant.
Results
Lipoaspirate was harvested from the lower abdomen via an
umbilical access point of five patients: a 12-year-old boy, a
17-year-old girl, a 27-year-old woman, a 64-year-old man,
and a 68-year-old woman (mean age, 37.6 ± 23.7 years).
No comorbidities were noted in the patient cohort.
Flow cytometry showed significantly higher levels of
ADSC in Telfa-processed lipoaspirate than in centrifuga-
tion-processed lipoaspirate (Fig. 2). The mean percentage of
cells expressing the combination CD73 and CD105 was 3.1
in the Telfa group and 4.3 in the centrifugation group
(P = 0.64). The cells expressing CD73 and CD44 were 2.3
in the centrifugation group and 6.5 in the Telfa group
(P = 0.0). Cells expressing CD73 and CD90 were 2.0 in the
centrifugation group and 5.7 in the Telfa group (P = 0.03).
Finally, the mean percentage of cells expressing the com-
bination CD90 and CD44 was 2.8 % in the centrifugation
group and 7.5 in the Telfa group (P = 0.05).
In a separate experiment, Telfa-processed liposapirate
resulted in an more viabile cells than centrifugation-pro-
cessed lipoaspirate (1.7 vs 1.3 [9106 cells]) (P = 0.25),
respectively (Fig. 3).
Discussion
Autologous fat grafting has myriad applications in plastic
and reconstructive surgery. The utility of this technique,
however, is limited by unpredictable resorption rates,
which reach 55 % [12–14]. Thus, much of the research has
Fig. 2 Flow cytometry for quantification of adipose-derived mesen-
chymal stem cell (ADSC) population proportions in centrifugation-
and Telfa-processed lipoaspirate. Mean ± standard error of mean.
*P \ 0.05
Fig. 3 Cell viability in centrifugation- and Telfa-processed lipoaspi-
rate. Mean ± standard error of mean. *P = 0.003
226 Aesth Plast Surg (2014) 38:224–229
123
focused on both development and refinement of harvesting
and processing techniques to improve fat graft viability,
with increasing emphasis placed on the importance of
ADSC.
Findings show that ADSCs are a widely accessible
population of precursor stem cells that exhibit trilineage
(adipogenic, chondrogenic, and osteogenic) differentiation
capacity [6]. The potential benefits of using ADSCs as an
adjunct therapy to improve fat graft survival have been
investigated previously. Studies have shown that supple-
mentation of fat grafts with ADSCs prolongs graft survival
and maintains fat graft viability (absence of necrosis or
fibrosis and increased vascularization) in animal fat graft
models [15–19].
Clinically, Yoshimura et al. [20] have shown cell-assisted
lipotransfer-mediated fat grafting (fat grafts enriched with
ADSCs and other cell populations) can be used to treat
facial lipoatrophy as well as breast augmentation [21] and
revision [13]. Furthermore, in a recent randomized con-
trolled trial by Kolle et al. [7], lipofilling with ex vivo
expanded ADSCs resulted in longer fat graft volume sur-
vival, providing supportive evidence that ADSC enrichment
may provide a benefit over traditional nonenriched fat grafts.
Although the mechanism of ADSC-mediated fat graft
survival has not been elucidated to date, it is posited that
mesenchymal stem cells provide a conducive environment
for graft vascularization and thus survival, primarily via
hypoxia-induced vascular endothelial growth factor
(VEGF)-mediated angiogenesis. Lu et al. [16] found that
fat graft survival was enhanced by ADSC enrichment and
further potentiated by VEGF supplementation. Similar
results were observed after enrichment of bone marrow–
derived mesenchymal stem cell–enriched fat grafts trans-
fected with VEGF [15].
Accumulating evidence suggests that ADSC concentra-
tions and cell viability can be influenced at all stages of the
fat-grafting process, from donor and donor-site selection to
graft placement. Multiple studies have examined anatomic
site-specific benefits from improvement of graft survival,
concluding that no donor site is superior in terms of graft
viability [22–24]. That being said, site-specific differences
in ADSC quantity and concentrations of other cell popu-
lations may exist because findings have shown the lower
abdomen and, to a lesser extent, the inner thigh to be
ADSC-enriched sources of lipoaspirates [25]. However, a
recent study comparing stromal vascular fraction cell iso-
lates (a cellular mixture including stromal cells, vascular
endothelial cells, and ADSCs—the fraction isolated in this
study) from multiple donor sites showed no difference in
stromal vascular fraction cell numbers or graft survival
among donor sites [23]. In spite of this, the lower abdomen
was chosen as the donor site for all samples in the current
study.
Clinicians generally accept that the process of fat har-
vesting should be performed in an atraumatic fashion. This
assertion is supported by multiple studies demonstrating
preservation of cell viability and function using atraumatic
techniques such as manual syringe aspiration rather than
more aggressive techniques such as machine-assisted
liposuction [26–29]. However, a recent study comparing
manual- and machine-simulated pressures on fat grafts
showed no difference in graft viability in an animal fat
graft model [30]. When a setting requires large volumes of
fat grafts (e.g., breast and buttock augmentation) versus
smaller volumes (e.g. facial contouring), manual suction
may be impractical and thus machine-assisted lipoaspira-
tion often is used.
The fat-processing techniques previously described in
the literature include centrifugation, filtering, decantation,
and washing. The decision which technique to use often is
dependent on the volume of fat required for transplantation,
the availability of equipment (e.g., centrifuge), and the
surgeon’s own personal preference. Centrifugation is a
common method of processing, especially for larger-vol-
ume fat grafts, although Telfa-based processing may be
more ideal for smaller volumes.
Although the benefits of Telfa-based processing have yet
to be tested, multiple studies have compared centrifugation
with filtering techniques in an attempt to establish a superior
processing method [31, 32]. In one study, centrifugation-
based processing resulted in higher ADSC numbers but
decreased cell viability counts than decantation [33]. The
findings of the current study echo these results in showing
that centrifugation may disrupt cell viability compared with
Telfa-rolling, especially at higher revolutions per minute [8,
9]. Interestingly, the current study also found that Telfa-
rolling resulted in greater ADSC yields, a surprising finding
considering the ability afforded by centrifugation to achieve
increased cell concentrations within processed fat.
The technique of fat graft placement at the recipient site
is a critical determinant of graft survival. Findings have
shown that larger grafts, as required for breast and buttock
augmentation, are more likely to fail, presumably because
of limited diffusion capacity and low oxygen tension
within the graft. Khouri et al. [12] overcame this obstacle
by implementing the practice of external expansion for
breast augmentation before grafting to increase the graft–
recipient surface interface and to facilitate diffusion and
revascularization, resulting in better graft survival.
A recent report found that the shear stress generated
along the cannula during graft placement is inversely
related to graft survival [30]. Although small-volume
grafting may not necessitate such measures as external
expansion, administering smaller aliquots of fat under low
injection pressure, as the cited study suggests, may
improve fat graft survival in all scenarios.
Aesth Plast Surg (2014) 38:224–229 227
123
The limitations to this study included the small sample
size and the absence of in vivo fat graft survival data.
Despite these limitations, the results, in addition to the
findings from previous laboratory and clinical studies,
suggest that Telfa-rolling processing of fat grafts may
provide a benefit over centrifugation. Laboratory-based
studies comparing the survival of fat grafts processed by
centrifugation or Telfa-rolling techniques are necessary to
provide a definitive answer.
Conclusion
This preliminary study demonstrated that Telfa-rolling fat
graft processing results in increased ADSC yields and cell
viability compared with centrifugation-based processing.
Telfa-rolling is an efficient and feasible preparation tech-
nique, particularly for lower-volume fat grafting, and may
provide ADSC-enriched samples.
Acknowledgments This study was supported by the Department of
Surgery, Yale University School of Medicine.
Disclosure All authors have no commercial associations or disclo-
sures that may pose or create a conflict of interest with the infor-
mation presented within this manuscript.
References
1. Coleman SR (2006) Facial augmentation with structural fat graft-
ing. Clin Plast Surg 33:567–577. doi:10.1016/j.cps.2006.09.002
2. Klinger M, Marazzi M, Vigo D, Torre M (2008) Fat injection for
cases of severe burn outcomes: a new perspective of scar
remodeling and reduction. Aesthet Plast Surg 32:465–469.
doi:10.1007/s00266-008-9122-1
3. Mojallal A et al (2009) Improvement of skin quality after fat
grafting: clinical observation and an animal study. Plast Reconstr
Surg 124:765–774. doi:10.1097/PRS.0b013e3181b17b8f
4. Phulpin B et al (2009) Rehabilitation of irradiated head and neck
tissues by autologous fat transplantation. Plast Reconstr Surg
123:1187–1197. doi:10.1097/PRS.0b013e31819f2928
5. Ranganathan K et al (2013) Fat grafting for thermal injury:
current state and future directions. J Burn Care Res 34:219–226.
doi:10.1097/BCR.0b013e318280e2dd
6. Zuk PA et al (2002) Human adipose tissue is a source of multi-
potent stem cells. Mol Biol Cell 13:4279–4295. doi:10.1091/mbc.
E02-02-0105
7. Kolle SF et al (2013) Enrichment of autologous fat grafts with
ex vivo expanded adipose tissue-derived stem cells for graft
survival: a randomised placebo-controlled trial. Lancet
382:1113–1120. doi:10.1016/S0140-6736(13)61410-5
8. Kim IH, Yang JD, Lee DG, Chung HY, Cho BC (2009) Evalu-
ation of centrifugation technique and effect of epinephrine on fat
cell viability in autologous fat injection. Aesthet Surg J 29:35–39.
doi:10.1016/j.asj.2008.09.004
9. Xie Y et al (2010) The effect of centrifugation on viability of fat
grafts: an evaluation with the glucose transport test. J Plast
Reconstr Aesthet Surg 63:482–487. doi:10.1016/j.bjps.2008.11.
056
10. Del Vecchio D, Rohrich RJA (2012) Classification of clinical fat
grafting: different problems, different solutions. Plast Reconstr
Surg 130:511–522. doi:10.1097/PRS.0b013e31825dbf8a
11. Wu W, Niklason L, Steinbacher DM (2013) The effect of age on
human adipose-derived stem cells. Plast Reconstr Surg
131:27–37. doi:10.1097/PRS.0b013e3182729cfc
12. Khouri RK et al (2012) Brava and autologous fat transfer is a safe
and effective breast augmentation alternative: results of a 6-year,
81-patient, prospective multicenter study. Plast Reconstr Surg
129:1173–1187. doi:10.1097/PRS.0b013e31824a2db6
13. Yoshimura K et al (2010) Progenitor-enriched adipose tissue
transplantation as rescue for breast implant complications. Breast
J 16:169–175. doi:10.1111/j.1524-4741.2009.00873.x
14. Zocchi ML, Zuliani F (2008) Bicompartmental breast lipostruc-
turing. Aesthetic Plast Surg 32:313–328. doi:10.1007/s00266-
007-9089-3
15. Chang L et al (2013) Improvement of the survival of autologous
free-fat transplants in rats using vascular endothelial growth
factor 165-transfected bone mesenchymal stem cells. Ann Plast
Surg. doi:10.1097/SAP.0b013e3182592db1
16. Lu F et al (2009) Improvement of the survival of human autol-
ogous fat transplantation by using VEGF-transfected adipose-
derived stem cells. Plast Reconstr Surg 124:1437–1446. doi:10.
1097/PRS.0b013e3181babbb6
17. Matsumoto D et al (2006) Cell-assisted lipotransfer: supportive
use of human adipose-derived cells for soft tissue augmentation
with lipoinjection. Tissue Eng 12:3375–3382. doi:10.1089/ten.
2006.12.3375
18. Moseley TA, Zhu M, Hedrick MH (2006) Adipose-derived stem
and progenitor cells as fillers in plastic and reconstructive surgery.
Plast Reconstr Surg 118:121S–128S. doi:10.1097/01.prs.
0000234609.74811.2e
19. Zhu M et al (2010) Supplementation of fat grafts with adipose-
derived regenerative cells improves long-term graft retention. Ann
Plast Surg 64:222–228. doi:10.1097/SAP.0b013e31819ae05c
20. Yoshimura K et al (2008) Cell-assisted lipotransfer for facial
lipoatrophy: efficacy of clinical use of adipose-derived stem cells.
Dermatol Surg 34:1178–1185. doi:10.1111/j.1524-4725.2008.
34256.x
21. Yoshimura K et al (2008) Cell-assisted lipotransfer for cosmetic
breast augmentation: Supportive use of adipose-derived stem/
stromal cells. Aesthet Plast Surg 32:48–55. doi:10.1007/s00266-
007-9019-4 discussion 56–47
22. Rohrich RJ, Sorokin ES, Brown SA (2004) In search of improved
fat transfer viability: A quantitative analysis of the role of cen-
trifugation and harvest site. Plast Reconstr Surg 113:391–395.
doi:10.1097/01.PRS.0000097293.56504.00 discussion 396–397
23. Li K et al (2013) Selection of donor site for fat grafting and cell
isolation. Aesthet Plast Surg 37:153–158. doi:10.1007/s00266-
012-9991-1
24. Ullmann Y et al (2005) Searching for the favorable donor site for
fat injection: in vivo study using the nude mice model. Dermatol
Surg 31:1304–1307
25. Padoin AV et al (2008) Sources of processed lipoaspirate cells:
influence of donor site on cell concentration. Plast Reconstr Surg
122:614–618. doi:10.1097/PRS.0b013e31817d5476
26. Crawford JL, Hubbard BA, Colbert SH, Puckett CL (2010) Fine
tuning lipoaspirate viability for fat grafting. Plast Reconstr Surg126:1342–1348. doi:10.1097/PRS.0b013e3181ea44a9
27. Pu LL, Coleman SR, Cui X, Ferguson RE Jr, Vasconez HC
(2008) Autologous fat grafts harvested and refined by the Cole-
man technique: A comparative study. Plast Reconstr Surg
122:932–937. doi:10.1097/PRS.0b013e3181811ff0
228 Aesth Plast Surg (2014) 38:224–229
123
28. Pu LL, Cui X, Fink BF, Cibull ML, Gao D (2005) The viability of
fatty tissues within adipose aspirates after conventional liposuc-
tion: A comprehensive study. Ann Plast Surg 54:288–292 dis-
cussion 292
29. Shiffman MA, Mirrafati S (2001) Fat transfer techniques: the
effect of harvest and transfer methods on adipocyte viability and
review of the literature. Dermatol Surg 27:819–826
30. Lee JH et al (2013) The effect of pressure and shear on autologous fat
grafting. Plast Reconstr Surg. doi:10.1097/PRS.0b013e3182879f4a
31. Minn KW, Min KH, Chang H, Kim S, Heo EJ (2010) Effects of fat
preparation methods on the viabilities of autologous fat grafts.
Aesthetic Plast Surg 34:626–631. doi:10.1007/s00266-010-9525-7
32. Ramon Y et al (2005) Enhancing the take of injected adipose
tissue by a simple method for concentrating fat cells. Plast Rec-
onstr Surg 115:197–201 discsussion 202–193
33. Conde-Green A, de Amorim NF, Pitanguy I (2010) Influence of
decantation, washing, and centrifugation on adipocyte and mes-
enchymal stem cell content of aspirated adipose tissue: a com-
parative study. J Plast Reconstr Aesthet Surg 63:1375–1381.
doi:10.1016/j.bjps.2009.07.018
Aesth Plast Surg (2014) 38:224–229 229
123